
Expedited Programs for Gene and Cellular Therapies
Early interaction with the relevant regulatory agencies allows for robust collaborations between the sponsor and agencies to ensure regulatory compliance. Starting these interactions in the preclinical phase is critical.
Toxicology Studies – Considerations for Design and Regulatory Requirements
Toxicology studies are not standard in design. There are many factors that need to be considered, such as relevant species, dosing route/frequency, dosing volume, duration of recovery phase and TK time points.
High-Resolution Mass Spectrometry eBook
Zamas Lam, Sr. VP, Global Head of Bioanalytical (MS) and Business Development (Preclinical and Bioanalysis), provides an in depth look at the uses and benefits of High Resolution Mass Spectrometry. QPS has partnered with SCIEX and Bioanalysis Zone to create and share this content.
Gene Interference eBook
In this eBook, Zamas Lam, Sr. VP, Global Head of Bioanalytical (MS) and Business Development (Preclinical and Bioanalysis), discusses gene interference and the benefits, uses and limitations of RNA and DNA therapies. QPS is proud to have worked with Bioanalysis Zone to produce this eBook.
ICH M10 Bioanalytical Method Validation eBook
Read compelling insights from Monique Putman, Director of Translational Medicine, in this review of the latest draft of the ICH M10 Guideline on Bioanalytical Method Validation. QPS is proud to have worked with Bioanalysis Zone to produce this eBook.
Stopping Alzheimer’s Disease (English)
Sevko and his partner Marlies share their experience participating in an extensive trial on a potential new drug for the treatment of neurological conditions such as Alzheimer’s Disease.
Stop de Ziekte van Alzheimer (Dutch)
Sevko en zijn partner Marlies hebben deelgenomen aan een uitgebreid onderzoek naar een mogelijk nieuw geneesmiddel voor de behandeling van een neurologische aandoeningen zoals de ziekte van Alzheimer.
Alzheimer’s Disease Blog Posts (Part I)
Explore a wide range of content related to Alzheimer’s Disease research into potential therapies, such as Neurofilament-Light Chain, Flortaucipir PET, exRNA Markers, Protein Shapes and more.
Alzheimer’s Disease Blog Posts (Part II)
Enjoy a series of short articles related to Alzheimer’s Disease research into potential therapies, such as Tau Propogation, MTBR-Tau-243, Marmosets as Primate Models, Retinal Scans, 13 newly discovered Alzheimer’s Genes and more.
Alzheimer’s Disease Blog Posts (Part III)
The QPS Neuropharmacology Blog is full of great information about Alzheimer’s disease. Alzheimer’s Disease Blog Posts (Part III) features radiation therapy, Morris Water Maze tests, p-tau181 proteins and more.